Patents by Inventor James Michael Dorsey

James Michael Dorsey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEROTONIN REUPTAKE INHIBITORS
    Publication number: 20120016124
    Abstract: A serotonin reuptake inhibitor which can be used in the treatment of depression and which has a decreased occurrence of unwanted side effects. The serotonin reuptake inhibitors are bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity. The serotonin-selective reuptake inhibitor (SSRI) homologue portion of the molecule shows an affinity to the serotonin reuptake transporter (SERT) and has antidepressant properties. The piperazine or piperidine portion of the molecule demonstrates an affinity to 5-HT receptors and restores the undesired side effects of SSRIs.
    Type: Application
    Filed: February 21, 2011
    Publication date: January 19, 2012
    Applicant: Baylor University
    Inventors: Kevin G. Pinney, Mada Graciata Miranda, James Michael Dorsey
  • Serotonin reuptake inhibitors
    Patent number: 7893261
    Abstract: A serotonin reuptake inhibitor which can be used in the treatment of depression and which has a decreased occurrence of unwanted side effects. The serotonin reuptake inhibitors are bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity. The serotonin-selective reuptake inhibitor (SSRI) homologue portion of the molecule shows an affinity to the serotonin reuptake transporter (SERT) and has antidepressant properties. The piperazine or piperidine portion of the molecule demonstrates an affinity to 5-HT receptors and restores the undesired side effects of SSRIs.
    Type: Grant
    Filed: March 28, 2005
    Date of Patent: February 22, 2011
    Assignee: Baylor University
    Inventors: Kevin G. Pinney, Maria Graciela Miranda, James Michael Dorsey
  • Serotonin Reuptake Inhibitors
    Publication number: 20080132514
    Abstract: A serotonin reuptake inhibitor which can be used in the treatment of depression and which has a decreased occurrence of unwanted side effects. The serotonin reuptake inhibitors are bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity. The serotonin-selective reuptake inhibitor (SSRI) homologue portion of the molecule shows an affinity to the serotonin reuptake transporter (SERT) and has antidepressant properties. The piperazine or piperidine portion of the molecule demonstrates an affinity to 5-HT receptors and restores the undesired side effects of SSRIs.
    Type: Application
    Filed: March 28, 2005
    Publication date: June 5, 2008
    Inventors: Kevin G. Pinney, Maria Graciela Miranda, James Michael Dorsey